Paratek Pharmaceuticals' Series C Round

Paratek Pharmaceuticals raised a round of funding on June 19, 2000.

Paratek is a biopharmaceutical company focused on the development, and commercialization of innovative antibiotics. Paratek's lead product candidate, omadacycline, is a novel tetracycline-derived, bro…

Articles about Paratek Pharmaceuticals' Series C Round: